EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC 4.0

Challenges and Opportunities in Exploring Non‐Motor Symptoms in 6‐Hydroxydopamine Models of Parkinson's Disease: A Systematic Review

Mateus Prates-Rodrigues iD, Beatriz Lage Araújo Schweizer iD, Clara de Paula Gomes iD, Ângela Maria Ribeiro, Fernando E Padovan-Neto iD, Debora Masini iD, Cleiton Lopes-Aguiar iD

Journal of Neurochemistry · 2025-02 · 169 (2)

DOI: 10.1111/jnc.70008 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Neurochemistry, online erschienen am 03.02.2025. Verfasst von Mateus Prates-Rodrigues und 6 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Fisiologia e Biofísica, Laboratório de Neurociências Comportamental e Molecular (LANEC), Universidade Federal de Minas Gerais, Belo H…. Hauptthemen laut MEDLINE: Oxidopamine, Parkinson Disease. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Amparo à Pesquisa do Estado de Minas Gerais, International Society for Neurochemistry (ISN), Career Development Grant (CDG).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson's disease (PD) is a neurodegenerative disorder characterized by the progressive loss of midbrain dopaminergic neurons, leading to motor symptoms such as tremors, rigidity, and bradykinesia. Non‐motor symptoms, including depression, hyposmia, and sleep disturbances, often emerge in the early stages of PD, but their mechanisms remain poorly understood. The 6‐hydroxydopamine (6‐OHDA) rodent model is a well‐established tool for preclinical research, replicating key motor and non‐motor symptoms of PD. In this review, we systematically analyzed 135 studies that used 6‐OHDA rodent models of PD to investigate non‐motor symptoms. The review process adhered to the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) guidelines. Our analysis highlights the growing use of 6‐OHDA PD models for experimental research of non‐motor symptoms. It also reveals significant variability in methodologies, including choices of brain target, toxin dosage, lesion verification strategies, and behavioral assessment reporting. Factors that hinder reproducibility and comparability of findings across studies. We highlight the need for standardization in 6‐OHDA‐based models with particular emphasis on consistent evaluation of lesion extent and reporting of the co‐occurrence of non‐motor symptoms. By fostering methodological coherence, this framework aims to enhance the reproducibility, reliability, and translational value of 6‐OHDA models in PD non‐motor symptom research. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OxidopamineParkinson DiseaseAnimalsDisease Models, AnimalHumans

Stichwörter der Autor:innen

6‐OHDAParkinson's diseaseanxietydepressionpreclinicalrodentsleepsocial interactionstriatumsubstantia nigra

Substanzen

Oxidopamine

Autor:innen und Institutionen

  • Departamento de Fisiologia e Biofísica, Laboratório de Neurociências Comportamental e Molecular (LANEC), Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
  • Department of Psychology, Faculty of Philosophy, Sciences and Letters of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil.
  • Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.

ORCID-Profile: Mateus Prates-Rodrigues, Beatriz Lage Araújo Schweizer, Clara de Paula Gomes, Fernando E Padovan-Neto, Debora Masini, Cleiton Lopes-Aguiar

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fundação de Amparo à Pesquisa do Estado de Minas Gerais
  • International Society for Neurochemistry (ISN), Career Development Grant (CDG)
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Zitieren

APA

Prates-Rodrigues, M., Schweizer, B. L. A., de Paula Gomes, C., Ribeiro, Â. M., Padovan-Neto, F. E., Masini, D., & Lopes-Aguiar, C. (2025). Challenges and Opportunities in Exploring Non‐Motor Symptoms in 6‐Hydroxydopamine Models of Parkinson's Disease: A Systematic Review. Journal of Neurochemistry, 169(2). https://doi.org/10.1111/jnc.70008

Vancouver

Prates-Rodrigues M, Schweizer BLA, de Paula Gomes C, Ribeiro ÂM, Padovan-Neto FE, Masini D, et al. Challenges and Opportunities in Exploring Non‐Motor Symptoms in 6‐Hydroxydopamine Models of Parkinson's Disease: A Systematic Review. Journal of Neurochemistry. 2025;169(2). doi:10.1111/jnc.70008

BibTeX
@article{PratesRodrigues2025,
  author = {Prates-Rodrigues, Mateus and Schweizer, Beatriz Lage Araújo and de Paula Gomes, Clara and Ribeiro, Ângela Maria and Padovan-Neto, Fernando E and Masini, Debora and Lopes-Aguiar, Cleiton},
  title = {Challenges and Opportunities in Exploring Non‐Motor Symptoms in 6‐Hydroxydopamine Models of Parkinson's Disease: A Systematic Review},
  journal = {Journal of Neurochemistry},
  year = {2025},
  volume = {169},
  number = {2},
  doi = {10.1111/jnc.70008}
}
Kostenlos starten →